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Early endovascular aneurysm repair after
percutaneous coronary interventions
Felice Pecoraro, MD,a,b Markus Wilhelm, MD,a Angela R. Kaufmann, MD,a Dominique Bettex, MD,c
Willibald Maier, MD,d Dieter Mayer, MD,a Frank J. Veith, MD,e and Mario Lachat, MD,a Zurich,
Switzerland; Palermo, Italy; and New York, NY
Objective: The objective of this study was to report long-term results of early endovascular aortic aneurysm repair after
percutaneous coronary intervention (PCI).
Methods: This was a retrospective analysis of all patients presenting with abdominal aortic aneurysm and coronary artery
disease treated during the same hospitalization by endovascular aortic aneurysm repair performed soon after PCI.
Primary outcomes were perioperative mortality, perioperative complications, survival after treatment, and freedom from
reintervention.
Results: A total of 20 patients were included, and all completed both procedures. No deaths or abdominal aortic
aneurysm ruptures occurred between the PCI and the aortic intervention. Perioperative mortality was 5% as one patient
died of mesenteric ischemia after endovascular aneurysm repair. Major cardiovascular vascular complications occurred
in four patients (20%) and included non-ST-segment elevation myocardial infarction (one) and access vessel compli-
cation (three). Mean follow-up was 94 (range, 1-164; standard deviation, 47) months. Estimated survival at 1 year,
2 years, 5 years, and 10 years was 90%, 90%, 90%, and 60%, respectively. A reoperation was required in six patients.
Estimated freedom from reintervention at 1 year, 2 years, 5 years, and 10 years was 83%, 83%, 78%, and 72%,
respectively.
Conclusions: Our study indicates that early endovascular aneurysm repair performed within a week after PCI may be a
reasonable approach in patients with large or symptomatic aneurysms. (J Vasc Surg 2015;61:1146-50.)
Abdominal aortic aneurysm (AAA) has a high inci-
dence globally.1 Since the introduction of endovascular
aneurysm repair (EVAR) by Volodos2 and Parodi,3 this
technique became the ﬁrst option in AAA treatment.
Compared with open surgery, this less invasive approach
has shown better short-term results and similar long-term
results.4 Although endovascular treatment signiﬁcantly re-
duces perioperative complications, myocardial infarction is
still the most frequent cause of death after aortic aneurysm
treatment.5 The same trend is observed in the long-term
period, with a fourfold risk increase of myocardial infarc-
tion in patients suffering cardiac symptoms preopera-
tively.6,7 In these patients, coronary artery disease (CAD)
treatment before aortic aneurysm repair is advocated to
reduce myocardial mortality. Both coronary artery bypass
grafting (CABG) and percutaneous coronary intervention
(PCI) are reported to be effective in reducing early and
late aneurysm-related mortality.8,9 Results with combined
PCI and early EVAR are missing. Herein we report our
experience with early EVAR after PCI in patients with
AAA and CAD with long-term follow-up.
METHODS
All patients treated by early EVAR after PCI between
January 1997 and December 2005 at the Clinic for Cardio-
vascular Surgery and the Clinic for Cardiology of Zurich
were evaluated. Informed consent for the procedure itself
and for the anonymous data collection and analysis was ob-
tained from all patients. The Institutional Review Board
approved the retrospective study.
An early EVAR procedure after PCI was indicated when
a patient selected for EVAR was preventively treated by PCI
for coronary disease during the same hospitalization. By deﬁ-
nition, at least a signiﬁcant coronary artery stenosis requiring
PCI intervention was present in all patients. A coronary ar-
tery stenosis >70% was considered angiographically signiﬁ-
cant. Both EVAR and PCI were performed according to a
board including vascular specialists, cardiologists, and anes-
thesiologists.10,11 Patients’ data collection was performed
prospectively within the in-house clinical information sys-
tems (KISIM 4.91; CISTEC AG, Zurich, Switzerland; and
Dendrite Clinical Systems, Oxfordshire, UK). Follow-up
data were obtained as “ﬁrst intention” through the clinical
information system; phone interviews were used when
follow-up data were missing. Data were analyzed in January
2014. Primary end points were perioperative mortality, peri-
operative complications, survival after treatment, and
freedom from reintervention. Perioperative outcomes were
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deﬁned as events occurring within 30 days. Demographic
and preoperative risk factors were also collected and
analyzed. History of CAD included typical symptoms, previ-
ous myocardial infarction, and clinical studies.12 Angina pec-
toris and dyspnea were classiﬁed according to the criteria of
the Canadian Cardiovascular Society (CCS)13 and the
New York Heart Association (NYHA).14 Peripheral artery
disease was deﬁned according to Rutherford classiﬁcation.15
Perioperative complications were divided into aneurysm
related, heart related, and lung related. Aneurysm-related
complications included abdominal bleeding, ileus, perito-
nitis, intestinal ischemia, abdominal compartment syndrome,
and type I and III endoleaks after EVAR treatment. Heart-
related complications included new perioperative myocardial
infarction, new cardiac arrhythmias, cardiac tamponade,
and congestive heart failure after PCI treatment. Lung-
related complications included pneumonia, pleural effusion
(>500 mL), pneumothorax requiring treatment, acute res-
piratory distress syndrome, and respiratory insufﬁciency. Ce-
rebral complications such as cerebrovascular insult (CVI)
and peripheral nerve lesions were also registered. Statistical
analysis was performed with SPSS 16.0 (SPSS Inc, Chicago,
Ill). Range and standard deviation (SD) are reported for
parametric data; absolute value and percentage are reported
for nonparametric data. Mean follow-up of the included pa-
tients was 94 (range,1-164; SD, 47) months.
RESULTS
In the study period, 20 consecutive patients were
treated intentionally by early EVAR after PCI. All were
treated during the same hospitalization and represent the
study cohort. Mean age was 75.5 (range, 59-89; SD, 8)
years, and all were male; associated comorbidities are re-
ported in the Table. Mean aneurysm diameter was 61.3
(range, 30-100; SD, 15) mm. In addition to the AAA,
two patients (10%) presented with a thoracic aortic aneu-
rysm. In three cases (15%), the AAA was symptomatic
with no rupture signs.
In all cases, thoracoabdominal computed tomography
angiography was used to evaluate the aortic aneurysm;
coronary angiography evaluated for CAD, and echocardi-
ography evaluated for heart functionality. One-vessel
CAD was present in ﬁve patients (25%), two-vessel disease
in eight patients (40%), and three-vessel disease in seven
patients (35%). Fifteen patients (75%) had an ejection frac-
tion >55%, four (20%) between 55% and 35%, and
one <35%. Eleven patients (55%) were asymptomatic ac-
cording to the NYHA criteria; seven (35%) were classiﬁed
in NYHA II and two (10%) in NYHA III. Seventeen pa-
tients (85%) were asymptomatic according to the CCS
criteria; the remaining three patients (15%) were classiﬁed
in CCS II. Six patients (30%) had no peripheral artery dis-
ease symptoms; six patients (30%) were classiﬁed as Ruth-
erford I, three patients (15%) as Rutherford II, and ﬁve
patients (25%) as Rutherford III. Of the 42 diseased coro-
nary vessels, 27 (64%) were revascularized. In 16 patients
(80%), coronary artery revascularization was performed
with stent (drug-eluting stent, 6; bare-metal stent, 10)
placement, whereas in four patients (20%), PCI consisted
of simple balloon angioplasty. The remaining 15 coronary
vessels (36%) were untreated for a nonsigniﬁcant stenosis
(50%-70% stenosis) in 12 or because the coronary artery
was considered irrelevant in 3. The right femoral artery
was employed as the PCI access site in 17 cases (85%),
the left femoral artery in the remaining 3 (15%). After
PCI, all patients were treated with a dual antiplatelet
regimen consisting of acetylsalicylic acid (100 mg/d) in
all cases plus ticlopidine (250 mg/d) or clopidogrel
(75 mg/d). The dual antiplatelet treatment was not inter-
rupted for the EVAR procedure. Mean interval from PCI
to EVAR was 2.5 (range, 0.1-7.0; SD, 2.7) days. EVAR
was performed with a commercially available bifurcated
stent graft in all cases. Excluder (Gore, Flagstaff, Ariz)
was used in 10 cases (50%); Vanguard (Boston Scientiﬁc,
Natick, Mass), in 6 cases (30%); Zenith (Cook Inc, Bloo-
mington, Ind), in 2 cases (10%); Endologix (Endologix,
Phoenix, Ariz), in 1 case (5%); and a hybrid device (Zenith
body and Excluder limbs), in the remaining case (5%).
Infrarenal ﬁxation devices (Excluder, Endologix) were
used when the proximal neck was >2 to 2.5 cm in length;
transrenal ﬁxation devices (Zenith, Vanguard) were used in
shorter necks. Mean proximal neck length was 2.2 (SD,
0.4) cm. In all cases, the device’s main body (trunk) was
introduced through a surgical arterial exposure (16 femoral
arteries and 4 external iliac arteries [EIAs]). In 12 cases, the
previous PCI access was surgically exposed to deliver the
device’s main body; in 4 cases, the femoral PCI access
site was not appropriate for the EVAR sheath size and
therefore the homolateral EIA was used; in the remaining
4 cases, the contralateral femoral artery was used. The
contralateral stent graft limb was introduced through a
percutaneous femoral access in 17 cases, the EIA in 2 cases,
and a femoral cutdown in the remaining case.
Local anesthesia was employed in all PCI (100%) and
in 17 (85%) EVAR procedures. No conversion from local
to general anesthesia was registered. The mean volume of
contrast material used for the EVAR and PCI procedures
was 124 (SD, 65) mL and 196 (SD, 76) mL, respectively.
Table. Patients’ associated comorbidities
No. (%)
Hypertension 16 (80)
Diabetes mellitus 4 (20)
Smoking 16 (80)
Lipid disorders 15 (75)
BMI >25 13 (60)
COPD 7 (35)
CKD 2 (10)
CVD 2 (10)
Previous MI 10 (50)
Double MI 1 (5)
Valvular/rhythm heart disease 2 (10)
BMI, Body mass index; COPD, chronic obstructive pulmonary disease;
CKD, chronic kidney disease; CVD, cerebrovascular disease;MI,myocardial
infarction.
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Mean in-hospital length of stay was 7 (range, 4-20; SD, 9)
days.
All patients completed PCI and early EVAR proce-
dures with no AAA rupture or death in the interval be-
tween the two procedures. One patient (5%) died after
the early EVAR procedure. This patient had a history of
myocardial infarction, CVI, and dialysis for chronic renal
failure. He suffered postoperatively of intestinal ischemia.
Ten perioperative complications occurred, including major
adverse cardiovascular complications in four patients (25%).
Heart-related complications included an acute non-ST-
segment elevation myocardial infarction after coronary
restenosis. In this case, initially treated with simple balloon
angioplasty, repeated balloon PCI was successful. Lung-
related complications were registered in two patients pre-
senting with a pneumothorax and a pleural effusion,
respectively. Aneurysm-related complications were regis-
tered in two patients presenting with an ileus. A type I
endoleak was registered in three cases. Two patients had
temporary deterioration of renal function, and one of these
required two sessions of hemodialysis. No signiﬁcant differ-
ence was observed in total contrast medium volume in pa-
tients developing transient renal function impairment (P ¼
.08). Three patients (15%) developed acute limb ischemia.
Of these, two patients had a PCI and EVAR access on the
same femoral artery. In the remaining case, a femoral cut-
down was performed after PCI access. No CVIs were regis-
tered. Estimated survival at 1 year, 2 years, 5 years, and
10 years was 90%, 90%, 90%, and 60%, respectively (Fig 1).
Overall, nine patients died during the follow-up. One
patient died perioperatively; the second died at postopera-
tive day 45 of global respiratory insufﬁciency and septic
shock. These two patients were excluded from the freedom
from reintervention end point. In the remaining 18 pa-
tients, a reoperation was required in 6 (33%). One patient
underwent repeated PCI for coronary artery stenosis. In
three patients, a type I endoleak was managed endovascu-
larly with proximal cuff extensions. The remaining two
reoperations were performed to treat patients presenting
with acute limb ischemia and consisted of femoral artery
thromboendarterectomy with polytetraﬂuoroethylene
patch in one case and lower limb peripheral bypass in the
remaining case. The third acute limb ischemia was
managed conservatively. Estimated freedom from reinter-
vention at 1 year, 2 years, 5 years, and 10 years was 83%,
83%, 78%, and 72%, respectively (Fig 2).
DISCUSSION
CAD is frequent in AAA patients,16,17 and it represents
the main cause of death after AAA repair.5,18-20 The Amer-
ican College of Cardiology and the American Heart Asso-
ciation of the American College of Physicians recommend,
for patients with unstable cardiac symptoms or advanced
CAD, coronary revascularization through CABG or
PCI.21 To reduce cardiac mortality during or after AAA
repair,6 a preventive coronary revascularization may be
advocated.22,23 Obviously, patients with large or enlarging
AAAs and patients with symptomatic AAAs should be
treated without much delay with graft replacement or
EVAR. In such clinical situations, the management of
CAD may be problematic. CABG and open AAA repair
preformed as a combined procedure efﬁciently treat both
pathologic processes but have shown good results only in
a few centers.24,25 Combined CABG and EVAR could
represent a better solution, but so far there are no data
to prove this. Thus, in most centers, a staged approach is
used.22 PCI and EVAR have been shown to be less invasive
and safer than the respective open repairs; thus, their com-
bination could be more appropriate.5,20,26 A strong argu-
ment in favor of PCI in patients with AAA is related to
the use of local anesthesia. In fact, general anesthesia
(with intubation and muscle relaxation) may be involved
in AAA rupture because of pressure modiﬁcation in
thoracic and abdominal compartments.27,28 However,
when coronary revascularization has been performed with
Fig 1. Cumulative survival. Standard error exceeds 10% at 7 years.
Fig 2. Cumulative freedom from reintervention. Standard error
exceeds 10% at 3 years.
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PCI, the Society for Vascular Surgery practice guidelines
suggest postponing elective AAA repair to reduce the risk
of coronary thrombosis.29 Delay between both procedures
should be 4 weeks after simple balloon angioplasty but may
last for 1 year when drug-eluting stents have been used.30
During the interval between coronary and aortic proce-
dures, patients are exposed to a higher AAA rupture
risk,22 probably related to the inﬂammatory response after
heart revascularization.24 AAA rupture has been reported
after 1 week from heart treatment; thus, to decrease AAA
rupture risk, a reduction of the interval time (<2 weeks)
has been proposed.22
So far, there is no experience or evidence on how to
proceed when EVAR is performed after PCI and what
the results are. In our patients, the early EVAR treatment
performed at a mean time interval of 2.5 (range, 0.1-7.0;
SD, 2.7) days after PCI was shown to be safe. The dura-
bility of these combined, less invasive procedures may be
an issue as, in both EVAR and PCI, reinterventions seem
to be more frequent. EVAR has been related to a higher
incidence of reoperations in the long term compared with
open AAA repair.4,31-33 A similar trend has been reported
with PCI in comparison to CABG, independently of the
type of coronary stent used.26 In this series, one patient
required repeated PCI and three patients required an addi-
tional procedure to treat type I endoleak during the follow-
up. However, in all four patients, these complications were
managed endovascularly. Endoleak incidence (six patients;
30.0%) seems to be high, but it has to be underlined that
the follow-up period extends for 8 years, with only three
patients who required a reintervention for type I endoleak.
Finally, this experience includes our EVAR learning curve,
especially in short necks, and some old devices, such as the
Vanguard, showed a high rate of material failure, especially
on the proximal ﬁxation segment. Peripheral vascular com-
plications during follow-up occurred in 15% (3 of 20) of
the patients, and in all these cases it concerned the femoral
artery that was used twice as an access site for PCI and
EVAR intervention. Thus, it should be recommended to
use alternative PCI access (radial or brachial artery) when
an early EVAR is planned.
The potential drawbacks of combined early EVAR after
PCI may be related to (1) the repeated use of contrast me-
dium within a short time that could increase risk of renal
dysfunction, (2) the need to perform EVAR under dual an-
tiplatelet therapy after PCI with a potential increased risk of
bleeding, and (3) the close time of two distinct surgical
stresses with a potential increase for mortality and
morbidity outcomes.
Simultaneous transcatheter aortic heart valve replace-
ment and PCI as single-stage procedures have been shown
to improve outcomes of patients presenting with CAD.34
Thus, in the area of hybrid operating rooms with high-
end ﬂuoroscopy, the questions arise if coronary and aortic
procedures may be done simultaneously and if this would
reduce coronary stent thrombosis, perioperative myocardial
infarction rate, and death. This will have to be addressed by
speciﬁc study.
The retrospective analysis and the small patient cohort
with no comparative group represent clear limitations of
the study. Because of our positive experience, since 1997
all patients presenting with a similar clinical situation and
clear indications for both procedures were treated with
early EVAR after PCI, and therefore we cannot build up
a consistent control group. Another important limitation
is that in our experience with early EVAR after PCI, we
cannot answer consistently if the risk of coronary artery
thrombosis may be higher after the use of drug-eluting
stents than after bare-metal stents or simple balloon angio-
plasty, as our groups are too small. However, this ﬁrst
report on EVAR performed early after PCI may be consid-
ered background for further comparative studies.
CONCLUSIONS
To date, there are no data reporting on early or long-
term outcomes in patients treated with early EVAR after
PCI. Our study indicates that early EVAR after PCI within
7 days may be a reasonable strategy to reduce cardiac
events and AAA rupture, especially in patients with large
or symptomatic aneurysms. EVAR can be safely performed
under dual antiplatelet therapy after PCI. This experience
justiﬁes reconsidering the general policy of postponing
EVAR for a long time when coronary angioplasty with
drug-eluting stents has been performed.
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